Sam Altman-backed Retro Biosciences to raise $1bn for project to extend human life 23 Jan 2025 Financial Times
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy 13 Jan 2025 Thermal
Using AI to design small molecule drugs is tough. Here are five companies trying to crack the code. 03 Dec 2024 STAT News
Ataraxis AI Launches to Transform Precision Medicine Beginning with World’s First AI-native Cancer Diagnostic 31 Oct 2024 Thermal
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases 24 Oct 2024 Thermal
With AI warning, Nobel winner joins ranks of laureates who’ve cautioned about the risks of their own work 13 Oct 2024 CNN
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement 01 Oct 2024 Thermal
The small-town Nobel Prize winner who wants to cure Alzheimer’s in 10 years 28 Sep 2024 The Telegraph
Meet the man who combines science, technology and magic to understand proteins 18 Jun 2024 Marketplace
AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality 20 May 2024 STAT News
Sam Altman’s mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences 23 Mar 2024 Business Insider
Profluent Secures $35M in Additional Funding and Key Industry Experts to Scale Foundational AI Models for Biomedicine and Tackle First Vertical in Gene Editing 21 Mar 2024 Thermal
BioAge raises $170M as obesity spotlight shifts to oral options, muscle preservers 13 Feb 2024 Endpoints News
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics 13 Feb 2024 Thermal
Innovative Genomics Institute and Danaher Join Forces to Accelerate and Scale Up the Development of CRISPR Cures 09 Jan 2024 Thermal
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most 08 Dec 2023 The New York Times
FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease 08 Dec 2023 The Wall St. Journal
FDA approves two sickle cell therapies, including first CRISPR medicine 08 Dec 2023 The Washington Post